StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Trading Down 100.0%
Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.12.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- What is a penny stock? A comprehensive guide
- Constellation Powers Up With Reinforced AI Data Center Strategy
- 5 Top Rated Dividend Stocks to Consider
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Breakout Stocks: What They Are and How to Identify Them
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
